Get started
MarketMoversReport

Axsome Therapeutics Announces FDA Approval of AUVELITY™

Long
Axsome Therapeutics, Inc. (NASDAQ:AXSM)  
MarketMoversReport  
NASDAQ:AXSM   Axsome Therapeutics, Inc.
Beyond Technical Analysis
0
0
beyondta
AXSM: Axsome Therapeutics, Inc.
2022-08-19 Axsome Therapeutics Announces FDA Approval of AUVELITY™, the First and Only Oral NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder in Adults
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.